<DOC>
	<DOCNO>NCT00899899</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor learn cancer development drug resistance patient . PURPOSE : This laboratory study look resistance methotrexate patient acute lymphoblastic leukemia relapse remission .</brief_summary>
	<brief_title>Resistance Methotrexate Patients With Acute Lymphoblastic Leukemia Relapse Remission</brief_title>
	<detailed_description>OBJECTIVES : - Determine mechanism intrinsic acquire methotrexate resistance use vitro assay match initial diagnosis , relapse , nonrelapsed ( control ) leukemic blast sample patient acute lymphoblastic leukemia relapse remission . - Determine mechanism acquire methotrexate resistance relate dosage time methotrexate administration clinical factor patient . OUTLINE : Random sample freeze leukemic blast relapse patient initial diagnosis relapse select . A corresponding sample nonrelapsing patient ( control ) initial diagnosis also randomly select . Reduced folate carrier ( RFC ) dehydrofolate reductase ( DHFR ) expression measure use quantitative reverse transcriptase-polymerase chain reaction assay prepared RNA . DHFR gene amplification measure dot blot analysis prepare DNA . Results assay use determine particular mechanism acquire methotrexate resistance associate particular subset acute lymphoblastic leukemia patient . Data collect regard actual timing dosage methotrexate receive patient correlate mechanisms resistance . PROJECTED ACCRUAL : A total 135 pair sample accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Acute lymphoblastic leukemia ( ALL ) relapse , include risk group leukemia subtypes , frozen leukemic blast sample store time initial diagnosis relapse Nonrelapsing ALL ( control ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
</DOC>